Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Bartsch

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2015
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patientsIgor Tsaur, Kristina Thurn, Eva Juengel, et al.
BJU International|March 7, 2008
Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortalityGeorg Bartsch, Wolfgang Horninger, Helmut Klocker, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 5, 2012
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancerRuprecht Kuner, Maria Fälth, Nicole Chui Pressinotti, et al.
Molecular Cancer|June 18, 2014
HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin AEva Juengel, Snigdha Nowaz, Jasmina Makarevi, et al.
European Urology|March 2, 2010
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detectionFlip H Jansen, Ron H N van Schaik, Joep Kurstjens, et al.
European Journal of Radiology|January 3, 2019
CT-guided nephrostomy-An expedient tool for complex clinical scenariosMaximilian Peter Brandt, Thomas Lehnert, Theresa Czilwik, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2009
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomyC Shad Thaxton, Robert Elghanian, Audrey D Thomas, et al.
Journal of the American Society for Mass Spectrometry|June 14, 2006
Material-enhanced laser desorption/ionization (MELDI)--a new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysisIsabel Feuerstein, Muhammad Najam-ul-Haq, Matthias Rainer, et al.
The Journal of Urology|October 14, 2015
Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the BladderGeorg Bartsch, Anirban P Mitra, Sheetal A Mitra, et al.
BJU International|January 22, 2008
Real-time virtual ultrasonographic radiofrequency ablation of renal cell carcinomaOsamu Ukimura, Michael Mitterberger, Koji Okihara, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Journal of Experimental & Clinical Cancer Research : CR|May 14, 2015
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patientsIgor Tsaur, Kristina Thurn, Eva Juengel, et al.
BJU International|March 7, 2008
Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortalityGeorg Bartsch, Wolfgang Horninger, Helmut Klocker, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 5, 2012
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancerRuprecht Kuner, Maria Fälth, Nicole Chui Pressinotti, et al.
Molecular Cancer|June 18, 2014
HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin AEva Juengel, Snigdha Nowaz, Jasmina Makarevi, et al.
European Urology|March 2, 2010
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detectionFlip H Jansen, Ron H N van Schaik, Joep Kurstjens, et al.
European Journal of Radiology|January 3, 2019
CT-guided nephrostomy-An expedient tool for complex clinical scenariosMaximilian Peter Brandt, Thomas Lehnert, Theresa Czilwik, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2009
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomyC Shad Thaxton, Robert Elghanian, Audrey D Thomas, et al.
Journal of the American Society for Mass Spectrometry|June 14, 2006
Material-enhanced laser desorption/ionization (MELDI)--a new protein profiling tool utilizing specific carrier materials for time of flight mass spectrometric analysisIsabel Feuerstein, Muhammad Najam-ul-Haq, Matthias Rainer, et al.
The Journal of Urology|October 14, 2015
Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the BladderGeorg Bartsch, Anirban P Mitra, Sheetal A Mitra, et al.
BJU International|January 22, 2008
Real-time virtual ultrasonographic radiofrequency ablation of renal cell carcinomaOsamu Ukimura, Michael Mitterberger, Koji Okihara, et al.
Pageof 30